
Mild clinical course of COVID-19 infection in chronic myeloid leukemia (CML) patients receiving tyrosine kinase inhibitors (TKIs) without interruption
Author(s) -
Judit Demeter,
Júlia Weisinger,
Zsolt Nagy
Publication year - 2021
Publication title -
mediterranean journal of hematology and infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.682
H-Index - 31
ISSN - 2035-3006
DOI - 10.4084/mjhid.2021.022
Subject(s) - medicine , myeloid leukemia , tyrosine kinase , covid-19 , immunology , virology , receptor , disease , outbreak , infectious disease (medical specialty)